Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02277119 · ClinicalTrials.gov registry record · NA
Clinical Study of the Optic Disc Parameters
A NA study, sponsored by Topcon Medical Systems.
- Completed
- Registry status
- NA
- Development phase
- 109
- Enrollment target
NCT02277119: Completed NA study, sponsored by Topcon Medical Systems.
NCT02277119 is a NA study that has completed, run by Topcon Medical Systems. The registered enrollment target is 109 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02277119, a NA study, has completed, sponsored by Topcon Medical Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 109 participants
- Enrollment target
Study Summary
Assess the repeatability and agreement of the Optic Disc Parameters, Retinal Nerve Fiber Layer (RNFL) Thickness, and Full Retinal Thickness between the Maestro and iVue OCT devices
Interventions
- DEVICE iVue
- DEVICE Maestro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2014-10 |
| Est. Completion | 2015-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02277119
The ClinicalTrials.gov registry entry for NCT02277119 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Topcon Medical Systems, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which iVue is the first listed.
NCT02277119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02277119 about?
NCT02277119 is a clinical study titled "Clinical Study of the Optic Disc Parameters". Assess the repeatability and agreement of the Optic Disc Parameters, Retinal Nerve Fiber Layer (RNFL) Thickness, and Full Retinal Thickness between the Maestro and iVue OCT devices
What is the current status of trial NCT02277119?
This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2014-10. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02277119?
The interventions under investigation include: iVue (DEVICE), Maestro (DEVICE).
Who is sponsoring clinical trial NCT02277119?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.